Institute of Microbiology of the Czech Academy of Sciences, Vestec, Czech Republic.
Department of Pediatrics, University Hospital of North Norway, Tromsø, Norway.
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.00666-20.
Vga(A) protein variants confer different levels of resistance to lincosamides, streptogramin A, and pleuromutilins (LSP) by displacing antibiotics from the ribosome. Here, we show that expression of (A) variants from is regulated by -regulatory RNA in response to the LSP antibiotics by the mechanism of ribosome-mediated attenuation. The specificity of induction depends on Vga(A)-mediated resistance rather than on the sequence of the riboregulator. Fine tuning between Vga(A) activity and its expression in response to the antibiotics may contribute to the selection of more potent Vga(A) variants because newly acquired mutation can be immediately phenotypically manifested.
Vga(A) 蛋白变体通过将抗生素从核糖体上置换下来,赋予了不同水平的林可酰胺类、链阳性菌素 A 和截短侧耳素(LSP)耐药性。在这里,我们表明,通过核糖体介导的衰减机制,来自 的 (A) 变体的表达受 -调节 RNA 调控,以响应 LSP 抗生素。诱导的特异性取决于 Vga(A)介导的耐药性,而不是核糖体调节剂的序列。Vga(A) 活性与其对抗生素表达之间的精细调节可能有助于选择更有效的 Vga(A)变体,因为新获得的突变可以立即表型化。